SrikanthAyyappan

True Marketeer, works at Parexel, one who literally lives to eat(ing) and read(ing) in that order &..& (Self-proclaimed) arbiter of taste. guess

[SrikanthAyyappan @srikanthayyappa]

Hear insights from Parexel's Sanjay Vyas on career growth, resilience, and leadership in Episode 3 of The Leadership Lounge with Antony Alex. Don’t miss his advice for aspiring leaders and the "On the Clock" segment towards the end! ⏲️
https://t.co/gzHebjt2rk

[SrikanthAyyappan @srikanthayyappa]

At OCT Europe, my colleague Suzanne McNally shared her experience with clinical trial ‘rescues' and how, with a proven phased approach, timely communication and planning ahead, they are entirely manageable. Read the recap in Clinical Trials Arena. 📖 https://t.co/R4Czfun8pp

[SrikanthAyyappan @srikanthayyappa]

If you’ve never interviewed someone before and are now tasked with doing so, don’t worry. Like any other skill, you can master “job interviewing” with practice. This article provides some advice that can fast-track your learning.
https://t.co/nBvSgbbbmT

[SrikanthAyyappan @srikanthayyappa]

Do you know how your employees truly feel about their roles, work, and relationships? This article outlines six questions to try to move beyond surface-level interactions. https://t.co/AUbaZQl3sL

[SrikanthAyyappan @srikanthayyappa]

What does 2025 hold for biotechs? My colleague, Jim Anthony (Head of Parexel Biotech), shares some compelling insights about how funding will continue to be critical, but understanding payer reimbursement for new therapies will be essential. Read more: https://t.co/1t30ExzkO4

[SrikanthAyyappan @srikanthayyappa]

Curious about a career with Parexel and the mission that fuels our work? Dive into our Careers Blog to learn from our colleagues about why they work With Heart and why they chose Parexel. Explore their stories here: https://t.co/B14KrrOEWP

#ParexelWithHeart hashtag#LifeAtParexel

[SrikanthAyyappan @srikanthayyappa]

The importance of reflection. At Parexel, we constantly strive for first-time quality in the fast-paced clinical research world. However, this article reminds us that true progress often comes from thoughtful reflection rather than constant activity.
https://t.co/Ybkp1DLL86

[SrikanthAyyappan @srikanthayyappa]

As the new year unfolds, setting professional resolutions can be a catalyst for career growth, personal development and sustained workplace success. In this article, Forbes suggests 4 goals around AI, networks, new responsibilities and work-life balance. https://t.co/4I1e02q836

[SrikanthAyyappan @srikanthayyappa]

India is on the cusp of becoming a global leader in healthcare innovation and addressing key ecosystem issues will be critical to unlock the next wave of growth. https://t.co/Xs3jiVuO9i

[SrikanthAyyappan @srikanthayyappa]

At Parexel, we're proud to champion women in leadership! Our programs have boosted women VPs from 33.5% to 45.6% in 10 years. Discover how you can grow with us. Learn more: https://t.co/zVbkFq4b8z

[SrikanthAyyappan @srikanthayyappa]

By making your strategy visible and easy to understand through storytelling, leveraging existing frameworks, and ensuring ongoing communication, you can shift perceptions, align your team with long-term goals, and be recognized for your strategic approach. https://t.co/txJXFLxlnu

[SrikanthAyyappan @srikanthayyappa]

What if we frame a value proposition for diversity on the return on investment for the organization, which benefits every individual and team and is rooted in science and backed by empirical research? Is this better suited to our current social tensions? https://t.co/g5PP0Ta51Q

[SrikanthAyyappan @srikanthayyappa]

This article highlights the importance of neuroinclusion in the workplace. Learn how embracing neurodiversity can boost innovation, attract top talent, and create a better work environment for all. https://t.co/T44M5NKwXO

[SrikanthAyyappan @srikanthayyappa]

India’s clinical research landscape presents both unique challenges and exciting opportunities for growth. In a conversation with ET Edge Insights, Parexel's Sanjay Vyas weighs in: https://t.co/W9CeAEKKAH

[SrikanthAyyappan @srikanthayyappa]

Parexel has made Forbes's list of best companies for women to work for in 2024, considering factors like flexibility for working parents and equal opportunities for advancement within the company! See the full list: https://t.co/KTifpu94wT

[SrikanthAyyappan @srikanthayyappa]

An FDA advisory committee recommends against PD-1 inhibitors as first-line treatment for ESCC patients with low/negative PD-L1 expression. Find out more from my colleagues Sinan Sarac and Gwyn Bebb in our latest Regulatory Navigator blog.
https://t.co/63fEjg8nZ8

[SrikanthAyyappan @srikanthayyappa]

A big congratulations to my colleagues in Japan, where Parexel was announced a Best CRO finalist in the 3rd annual #CitelineJapan Awards! Looking forward to Oct. 22, when the winners will be announced in Tokyo! 🏆🏆
https://t.co/9iSEMIQbCU
#ParexelJapan #Citeline

[SrikanthAyyappan @srikanthayyappa]

Everyone working in clinical trials must embrace the opportunity to re-evaluate and standardize reimbursement policies to improve patient participation in research. Hear from Parexel's Chief Patient Officer, Stacy Hurt, in this article from STAT news: https://t.co/jE87OFYBpA

[SrikanthAyyappan @srikanthayyappa]

Parexel's Leslie Johnson shares insights in this Contract Pharma article exploring the opportunities and challenges of gene therapies. Read it here: https://t.co/aE2X1Wtmeg

[SrikanthAyyappan @srikanthayyappa]

Parexel implemented a direct-to-patient application to recruit diverse patients and collect RWD. Read more in this article just published by ISPOR in the Value & Outcomes Spotlight. https://t.co/HoNpFgl3Q3